133 related articles for article (PubMed ID: 37928427)
21. [Identification of differentially expressed genes between lung adenocarcinoma and squamous cell carcinoma using transcriber signature analysis].
Peng S; Li X; Liu Q; Zhang Y; Zou L; Gong X; Wang M; Ma X
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jun; 39(6):641-649. PubMed ID: 31270041
[TBL] [Abstract][Full Text] [Related]
22. THOC3 interacts with YBX1 to promote lung squamous cell carcinoma progression through PFKFB4 mRNA modification.
Yu T; Zhang Q; Yu SK; Nie FQ; Zhang ML; Wang Q; Lu KH
Cell Death Dis; 2023 Jul; 14(7):475. PubMed ID: 37500615
[TBL] [Abstract][Full Text] [Related]
23. Shared network pattern of lung squamous carcinoma and adenocarcinoma illuminates therapeutic targets for non-small cell lung cancer.
Li P; Kuang X; Zhang T; Ma L
Front Surg; 2022; 9():958479. PubMed ID: 36263088
[TBL] [Abstract][Full Text] [Related]
24. Network module function enrichment analysis of lung squamous cell carcinoma and lung adenocarcinoma.
Li P; Yuan H; Kuang X; Zhang T; Ma L
Medicine (Baltimore); 2022 Nov; 101(47):e31798. PubMed ID: 36451444
[TBL] [Abstract][Full Text] [Related]
25. GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma.
Ning J; Jiang S; Li X; Wang Y; Deng X; Zhang Z; He L; Wang D; Jiang Y
BMC Pulm Med; 2021 Jun; 21(1):199. PubMed ID: 34112123
[TBL] [Abstract][Full Text] [Related]
26. Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Li N; Wang J; Zhan X
Front Immunol; 2021; 12():752643. PubMed ID: 34887858
[TBL] [Abstract][Full Text] [Related]
27. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
Liu X; Chen L; Zhang T
Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532
[TBL] [Abstract][Full Text] [Related]
28. High KIF2A expression promotes proliferation, migration and predicts poor prognosis in lung adenocarcinoma.
Xie T; Li X; Ye F; Lu C; Huang H; Wang F; Cao X; Zhong C
Biochem Biophys Res Commun; 2018 Feb; 497(1):65-72. PubMed ID: 29427669
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
[TBL] [Abstract][Full Text] [Related]
30. Identification of specific prognostic markers for lung squamous cell carcinoma based on tumor progression, immune infiltration, and stem index.
Wu R; Ma R; Duan X; Zhang J; Li K; Yu L; Zhang M; Liu P; Wang C
Front Immunol; 2023; 14():1236444. PubMed ID: 37841237
[TBL] [Abstract][Full Text] [Related]
31. High expression of SLC6A10P contributes to poor prognosis in lung adenocarcinoma.
Yuan K; Gao ZJ; Yuan WD; Yuan JQ; Wang Y
Int J Clin Exp Pathol; 2018; 11(2):720-726. PubMed ID: 31938158
[TBL] [Abstract][Full Text] [Related]
32. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.
Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H
Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503
[TBL] [Abstract][Full Text] [Related]
33. Up-Regulation of CCT8 Related to Neuronal Apoptosis after Traumatic Brain Injury in Adult Rats.
Wu X; Zhang H; Chen D; Song Y; Qian R; Chen C; Mao X; Chen X; Zhang W; Shao B; Shen J; Yan Y; Wu X; Liu Y
Neurochem Res; 2015 Sep; 40(9):1882-91. PubMed ID: 26285900
[TBL] [Abstract][Full Text] [Related]
34. Discoidin domain receptor 1 promotes lung adenocarcinoma migration via the AKT/snail signaling axis.
Zhu J; Cheng H; Wang L; Xu W; Wang J; Han Q; Lee JH; Du L; Lyu J
Mol Biol Rep; 2022 Aug; 49(8):7275-7286. PubMed ID: 35562515
[TBL] [Abstract][Full Text] [Related]
35. Targeting STT3A produces an anti-tumor effect in lung adenocarcinoma by blocking the MAPK and PI3K/AKT signaling pathway.
Cheng J; Xia L; Hao X; Gan F; Bai Y; Zhang C; Mao Y; Zhu Y; Pu Q; Park DW; Tavolari S; Mei J; Chen Y; Deng S; Liu L
Transl Lung Cancer Res; 2022 Jun; 11(6):1089-1107. PubMed ID: 35832442
[TBL] [Abstract][Full Text] [Related]
36. CASC5 is a potential tumour driving gene in lung adenocarcinoma.
Cui Y; Zhang C; Ma S; Guo W; Cao W; Guan F
Cell Biochem Funct; 2020 Aug; 38(6):733-742. PubMed ID: 32283571
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive bioinformatics analysis on exportins in lung adenocarcinoma and lung squamous cell carcinoma.
Pan M; Huang P; Li L; Lei P; Fang L; Zhao L; Li Y; Huang S; Luo W
J Thorac Dis; 2023 Apr; 15(4):1872-1891. PubMed ID: 37197486
[TBL] [Abstract][Full Text] [Related]
38. Identification of the prognostic and therapeutic values of cyclin E1 (
Ullah MA; Farzana M; Islam MS; Moni R; Zohora US; Rahman MS
Heliyon; 2022 Sep; 8(9):e10367. PubMed ID: 36091953
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive Analysis of Immune Implication and Prognostic Value of
Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W
Front Oncol; 2021; 11():798425. PubMed ID: 35047409
[TBL] [Abstract][Full Text] [Related]
40. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]